Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Stopped The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.

Conditions

• Influenza
• Influenza Vaccines

Interventions

• BIOLOGICAL: GSK Bio's influenza vaccine GSK2584786A, different formulations
• BIOLOGICAL: GSK Bio's influenza vaccine GSK2321138A
• BIOLOGICAL: Fluarix™

Sponsor

GlaxoSmithKline